Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Aclaris Therapeutics Inc (NASDAQ: ACRS) closed at $1.66 down -9.29% from its previous closing price of $1.83. In other words, the price has decreased by -$9.29 from its previous closing price. On the day, 0.91 million shares were traded.
Ratios:
For a deeper understanding of Aclaris Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.99 and its Current Ratio is at 3.99. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Leerink Partners Upgraded its Market Perform to Outperform on November 19, 2024, whereas the target price for the stock was revised from $2 to $7.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 19 ’24 when Mehra Anand bought 666,666 shares for $2.25 per share. The transaction valued at 1,499,998 led to the insider holds 710,030 shares of the business.
Leonard Braden Michael bought 206,025 shares of ACRS for $256,357 on Aug 05 ’24. The 10% Owner now owns 14,250,000 shares after completing the transaction at $1.24 per share. On Aug 02 ’24, another insider, Leonard Braden Michael, who serves as the 10% Owner of the company, bought 167,544 shares for $1.29 each. As a result, the insider paid 216,400 and bolstered with 14,043,975 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 9.57 while its Price-to-Book (P/B) ratio in mrq is 1.15.
Stock Price History:
Over the past 52 weeks, ACRS has reached a high of $5.17, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is -29.37%, while the 200-Day Moving Average is calculated to be -10.70%.
Shares Statistics:
A total of 107.85M shares are outstanding, with a floating share count of 91.37M. Insiders hold about 15.34% of the company’s shares, while institutions hold 68.59% stake in the company.
